- Home
- INZY vs CATO Comparison
INZY vs CATO Comparison
Compare INZY & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- CATO
- Stock Information
- Founded
- INZY 2015
- CATO 1946
- Country
- INZY United States
- CATO United States
- Employees
- INZY N/A
- CATO N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- CATO Clothing/Shoe/Accessory Stores
- Sector
- INZY Health Care
- CATO Consumer Discretionary
- Exchange
- INZY Nasdaq
- CATO Nasdaq
- Market Cap
- INZY 64.9M
- CATO 55.7M
- IPO Year
- INZY 2020
- CATO N/A
- Fundamental
- Price
- INZY $3.97
- CATO $2.56
- Analyst Decision
- INZY Buy
- CATO
- Analyst Count
- INZY 9
- CATO 0
- Target Price
- INZY $15.22
- CATO N/A
- AVG Volume (30 Days)
- INZY 5.3M
- CATO 43.9K
- Earning Date
- INZY 05-14-2025
- CATO 05-22-2025
- Dividend Yield
- INZY N/A
- CATO 13.28%
- EPS Growth
- INZY N/A
- CATO N/A
- EPS
- INZY N/A
- CATO N/A
- Revenue
- INZY N/A
- CATO $642,949,000.00
- Revenue This Year
- INZY N/A
- CATO N/A
- Revenue Next Year
- INZY N/A
- CATO N/A
- P/E Ratio
- INZY N/A
- CATO N/A
- Revenue Growth
- INZY N/A
- CATO N/A
- 52 Week Low
- INZY $0.72
- CATO $2.19
- 52 Week High
- INZY $6.24
- CATO $6.70
- Technical
- Relative Strength Index (RSI)
- INZY 85.93
- CATO 47.88
- Support Level
- INZY $3.94
- CATO $2.50
- Resistance Level
- INZY $3.97
- CATO $2.89
- Average True Range (ATR)
- INZY 0.08
- CATO 0.19
- MACD
- INZY 0.12
- CATO 0.01
- Stochastic Oscillator
- INZY 99.32
- CATO 28.85
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.